Nasdaq Snti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq snti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Snti Today - Breaking & Trending Today

Senti Biosciences, Inc. (NASDAQ:SNTI) Short Interest Down 44.4% in November

Senti Biosciences, Inc. (NASDAQ:SNTI – Get Free Report) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 834,000 shares, a decline of 44.4% from the November 15th total of 1,500,000 shares. Based on an average trading volume of 2,570,000 shares, the days-to-cover ratio […] ....

Renaissance Technologies , Millennium Management , Virtu Financial , Senti Biosciences Inc , Geode Capital Management , Senti Biosciences , Get Free Report , Capital Management , Triatomic Management , Senti Biosciences Daily , Nasdaq Snti ,

Triatomic Management LP Grows Position in Senti Biosciences, Inc. (NASDAQ:SNTI)

Triatomic Management LP boosted its stake in shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Free Report) by 42.5% during the 2nd quarter, Holdings Channel reports. The firm owned 300,533 shares of the company’s stock after acquiring an additional 89,650 shares during the quarter. Triatomic Management LP’s holdings in Senti Biosciences were worth $188,000 as of […] ....

Pricet Rowe Associates Inc , Exchange Commission , Millennium Management , Geode Capital Management , Virtu Financial , Senti Biosciences Inc , Holdings Channel , Renaissance Technologies , Triatomic Management , Senti Biosciences , Free Report , Capital Management , Get Free Report , Chardan Capital , Visit Holdingschannel , Senti Biosciences Daily , Nasdaq Snti , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Senti Biosciences, Inc. (NASDAQ:SNTI) Short Interest Update

Senti Biosciences, Inc. (NASDAQ:SNTI – Get Free Report) was the recipient of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,500,000 shares, an increase of 260.1% from the October 31st total of 416,500 shares. Approximately 5.7% of the shares of the company are […] ....

Virtu Financial , Renaissance Technologies , Millennium Management , Senti Biosciences Inc , Td Asset Management Inc , Senti Biosciences Company Profile , Senti Biosciences , Get Free Report , Management Inc , Triatomic Management , Chardan Capital , Senti Biosciences Daily , Nasdaq Snti ,

Senti Bio Announces Multiple Data Presentations at the

– Two poster presentations highlighting new preclinical data with BlueRock Therapeutics – – Two poster presentations showcasing Senti Bio’s proprietary. ....

San Diego , United States , Timothy Lu , Senti Biosciences Inc , Securities Exchange , Society For Immunotherapy Of Cancer , Exchange Commission , Bluerock Therapeutics , Senti Bio , Gene Circuit , Annual Meeting , Chief Executive Officer , Poster Halls , Logic Gating , Logic Gated , Logic Gate , Gene Circuits , Spark Therapeutics , Securities Act , Securities Exchange Act , Senti Biosciences , Nasdaq Snti , Senti Biosciences ,

Analysts Offer Predictions for Senti Biosciences, Inc.'s FY2023 Earnings (NASDAQ:SNTI)

Senti Biosciences, Inc. (NASDAQ:SNTI – Free Report) – Equities researchers at Chardan Capital lowered their FY2023 EPS estimates for shares of Senti Biosciences in a report issued on Tuesday, August 15th. Chardan Capital analyst Y. Livshits now expects that the company will earn ($1.05) per share for the year, down from their prior estimate of […] ....

Millennium Management , Senti Biosciences Company Profile , Virtu Financial , Renaissance Technologies , Senti Biosciences Inc , Geode Capital Management , Senti Biosciences , Free Report , Chardan Capital , Senti Bioscience , Capital Management , Triatomic Management , Get Free Report , Senti Biosciences Daily , Nasdaq Snti , Earnings Estimates ,